Glucofrangulin A
CAS: 21133-53-9
Ref. 3D-WAA13353
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen | ||
100mg | Ausgelaufen |
Produktinformation
- 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-1-(beta-D-glucopyranosyloxy)-8-hydroxy-6-methylanthraquinone
- 3-[(6-Deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)oxy]-1-(β-<smallcap>D</span>-glucopyranosyloxy)-8-hydroxy-6-methyl-9,10-anthracenedione
- 3-[(6-Deoxyhexopyranosyl)Oxy]-8-Hydroxy-6-Methyl-9,10-Dioxo-9,10-Dihydroanthracen-1-Yl Hexopyranoside
- 9,10-Anthracenedione, 3-[(6-deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)oxy]-1-(β-<smallcap>D</span>-glucopyranosyloxy)-8-hydroxy-6-methyl-
- Glucofragulin A
Glucofrangulin A is a laxative that has been used in the treatment of constipation. It is chemically classified as an anthraquinone glycoside and has been shown to have genotoxic activity. Glucofrangulin A has laxative properties, which are due to its ability to decrease water absorption by the intestine. Glucofrangulin A was found to be effective in experiments with mice and rats, but not in human studies. Glucofrangulin A also contains sennoside, which is a chemical substance that can induce diarrhea. The laxative effect of Glucofrangulin A is due to its ability to increase peristaltic activity and inhibit the absorption of water from the intestine.